004B Routine QOF work | j CV Focus

004B Routine QOF work | j CV Focus

This folder contains searches to identify patients at high cardiovascular (CV) risk, with a specific focus on blood pressure control, statin prescribing, and HbA1c levels. It is especially useful for practices aiming to optimise outcomes for CHD, stroke/TIA, diabetes, and hypertension indicators.

Warning
The searches have been built to look at the contract year (1st April to 31st March), so it is recommended to run the search WITHOUT a relative run date.

🔎 CV | 1–4 blood pressure indicators outstanding

These four searches identify patients with 1, 2, 3, or 4 QOF BP indicators not yet met:

  • CHD015/016

  • STIA014/015

  • HYP008/009

  • DM036

Use these to prioritise patients with the greatest number of outstanding BP indicators.

🔎 CV | BP last month not to target NO previous PCAs HAS new antihypertensives

Identifies patients recently escalated on treatment but still not at BP target.

  • These patients may need follow-up blood pressure readings to confirm improvement.

🔎 CV | BP last month not to target NO previous PCAs BP 160/100 to 180/110

Patients with moderately raised BP and no PCA recorded within the last 3 years, or new medication added in the last 6 weeks.

🔎 CV | BP last month not to target NO previous PCAs BP >180/110

Patients with severely raised BP and no recent action taken.

  • Consider urgent review or escalation.

🔎 CV | BP last month not to target NO previous PCAs BP<160/100

Patients with mildly raised BP that may still affect QOF achievement if left unaddressed.

📋 INTENSIFY | Cholesterol LDL this year >2.0

Patients with LDL >2.0 mmol/L this year who may benefit from treatment intensification.

📋 INTENSIFY | Cholesterol LDL this year borderline

Patients just above the threshold LDL level (i.e. between 2.0 and 3.0), especially relevant for patients with CVD or diabetes.
If no LDL level present, similar nHDL range 2.6 to 3.6 is shown.

📋 INTENSIFY | DM020 HbA1c this year and HbA1c >58 mmol/mol

Supports DM020
Non-frail patients with raised HbA1c results requiring therapy review or intensification.

📋 INTENSIFY | DM021 HbA1c this year and HbA1c >75 mmol/mol

Supports DM021
Frail patients with significantly raised HbA1c.

  • Consider review or PCA depending on clinical context.

📋 START | Cholesterol not on a statin NO previous PCAs

Patients not on statin therapy, eligible for QOF indicators, with no PCA coded.

  • Useful for identifying patients who may need therapy initiated.